Shares in 23andMe are currently trading at around $3.40, giving it a valuation of just under $82 million. The company went ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...

Me (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic ...

Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months ...

Founded in 2006, 23andMe seized consumer interest with its genetic-testing kits that offered customers breakdowns of their ancestry. In 2017, it started selling tests designed to help assess a ...

23andMe aims to empower individuals with actionable insights to enhance prevention and treatment strategies. The report integrates data from genetic markers, ancestry, and birth sex to evaluate ...

SUNNYVALE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help ...

The genetic testing company ended last year with $79.4 million and told investors it will need to raise money to fund its operations and financial commitments.